Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect ...

Dr Chu-Yueh Guo prepares to discover how the latest diagnostic criteria and breakthrough treatments are reshaping the ...

To confront its GP shortage, Australia is expanding rural training, funding, and new medical school models to rebuild its ...

Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.

"I find the consistency across age, race, BMI, and glycemic status more clinically exciting than the sex difference," said ...

Anemia affects more than 1 in 4 pregnant individuals in the US, with prevalence increasing from prenatal care initiation to ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Under NICE’s final draft guidance, vorasidenib (Voranigo, Servier Laboratories) is indicated for patients with grade 2 astrocytoma or oligodendroglioma with susceptible isocitrate dehydrogenase (IDH1 ...

Adalimumab and ixekizumab show comparable effectiveness in improving joint outcomes and achieving remission in patients with psoriatic arthritis over 12 months, according to a real-world study.

Continuous glucose monitoring is expanding beyond type 1 diabetes, offering detailed glycemic insights that may support earlier intervention in patients with type 2 diabetes.

In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK ...

In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is ...